Voltage-gated ion channels are implicated in pain sensation and transmission signaling mechanisms within both peripheral nociceptors and the spinal cord. Genetic knockdown and knockout experiments have shown that specific channel isoforms, including Na V 1.7 and Na V 1.8 sodium channels and Ca V 3.2 T-type calcium channels, play distinct pronociceptive roles. We have rationally designed and synthesized a novel small organic compound (Z123212) that modulates both recombinant and native sodium and calcium channel currents by selectively stabilizing channels in their slow-inactivated state. Slow inactivation of voltage-gated channels can function as a brake during periods of neuronal hyperexcitability, and Z123212 was found to reduce the excitability of both peripheral nociceptors and lamina I/II spinal cord neurons in a state-dependent manner. In vivo experiments demonstrate that oral administration of Z123212 is efficacious in reversing thermal hyperalgesia and tactile allodynia in the rat spinal nerve ligation model of neuropathic pain and also produces acute antinociception in the hot-plate test. At therapeutically relevant concentrations, Z123212 did not cause significant motor or cardiovascular adverse effects. Taken together, the state-dependent inhibition of sodium and calcium channels in both the peripheral and central pain signaling pathways may provide a synergistic mechanism toward the development of a novel class of pain therapeutics. Ó
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Introduction
Voltage-gated sodium (Na V ) and calcium (Ca V ) channels are crucially involved in nociceptive signaling pathways, in part by mediating ionic currents that contribute to the excitability of peripheral nociceptors in the dorsal root ganglia (DRG). A specific subtype of T-type Ca V channel (Ca V 3.2) is highly expressed in DRG neurons and is involved in the initiation of action potential (AP) firing and the generation of burst firing [6, 19, 31, 42] . Both tetrodotoxin (TTX)-sensitive Na V 1.7 and TTX-resistant Na V 1.8 channels are also robustly expressed in DRGs and are important for setting the threshold and upstroke of AP firing, respectively, and further act to influence the frequency and sustainability of firing [10] .
Within the spinal cord dorsal horn, second-order neurons in superficial layers (lamina I/II) relay nociceptive-specific signals from peripheral nociceptors to pain-processing regions of the brain. Evidence suggests that a variety of Na V and Ca V channel isoforms are expressed within lamina I/II neurons [14, 42, 45] and that both Na V and Ca V channels may increase the excitability of dorsal horn neurons linked to neuropathic and inflammatory pain signaling [11, 14, 20] . Specific Na V and Ca V isoforms have been shown to play pronociceptive roles; knockout of either Na V 1.7 or Na V 1.8 channels or knockdown of Ca V 3.2 T-type channels reduces hyperalgesia and allodynia in animal models of acute and neuropathic pain [6, 25, 30] . In humans, loss-of-function mutations in the Na V 1.7 channel lead to complete abolition of pain sensation, while gain-of-function Na V 1.7 mutations cause severe chronic pain syndromes [10] .
